Matthew Harrison
Stock Analyst at Morgan Stanley
(3.44)
# 919
Out of 4,944 analysts
697
Total ratings
48.58%
Success rate
3.14%
Average return
Main Sectors:
Stocks Rated by Matthew Harrison
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LEGN Legend Biotech | Maintains: Overweight | $81 → $83 | $37.40 | +121.93% | 13 | Aug 12, 2025 | |
| IOBT IO Biotech | Maintains: Overweight | $6 → $4 | $1.28 | +212.50% | 6 | Aug 12, 2025 | |
| VRTX Vertex Pharmaceuticals | Maintains: Equal-Weight | $460 → $439 | $391.03 | +12.27% | 41 | Aug 5, 2025 | |
| REGN Regeneron Pharmaceuticals | Maintains: Overweight | $754 → $761 | $556.00 | +36.87% | 55 | Aug 4, 2025 | |
| BIIB Biogen | Maintains: Equal-Weight | $146 → $144 | $133.11 | +8.18% | 54 | Aug 1, 2025 | |
| ARGX argenx SE | Maintains: Overweight | $700 → $766 | $637.46 | +20.16% | 25 | Aug 1, 2025 | |
| SRPT Sarepta Therapeutics | Maintains: Equal-Weight | $15 → $20 | $19.22 | +4.06% | 38 | Jul 29, 2025 | |
| BMRN BioMarin Pharmaceutical | Maintains: Overweight | $97 → $96 | $57.39 | +67.28% | 22 | Jul 22, 2025 | |
| INSM Insmed | Maintains: Overweight | $102 → $108 | $121.72 | -11.27% | 18 | Jul 17, 2025 | |
| R Ryder System | Initiates: Positive | $215 | $180.63 | +19.03% | 1 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $130 → $135 | $121.05 | +11.52% | 42 | Apr 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $6.2 → $6 | $3.57 | +68.07% | 10 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $39 → $32 | $26.73 | +19.72% | 25 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $5 | $0.82 | +513.50% | 5 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Overweight | $41 → $33 | $13.95 | +136.56% | 12 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $160 → $178 | $159.02 | +11.94% | 1 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $56 | $34.58 | +61.94% | 2 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $57 → $55 | $32.65 | +68.45% | 2 | Jan 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $10 → $3 | $2.12 | +41.51% | 10 | Nov 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $8 → $11 | $17.15 | -35.84% | 9 | Jun 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $38 → $8 | $1.48 | +442.37% | 4 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $7 | $2.87 | +144.33% | 18 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $34 | $21.35 | +59.25% | 14 | Apr 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $32 | $22.46 | +42.51% | 27 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $21 → $19 | $3.63 | +424.14% | 3 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $2 → $1 | $0.79 | +26.58% | 3 | Mar 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $13 → $10 | $20.38 | -50.93% | 9 | Mar 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $27 → $8 | $6.59 | +21.40% | 9 | Feb 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $57 → $44 | $32.25 | +36.46% | 28 | Feb 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $13 | $3.18 | +308.81% | 3 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $140 → $80 | $10.00 | +700.40% | 4 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $100 → $60 | $5.51 | +988.93% | 4 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $203 → $216 | $112.63 | +91.78% | 8 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $7 → $5 | $3.08 | +62.34% | 13 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $5 | $2.18 | +129.36% | 6 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $178 → $182 | $201.12 | -9.51% | 8 | Dec 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $12 → $9 | $8.48 | +6.13% | 13 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $30 → $40 | $48.65 | -17.78% | 6 | Nov 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $279 → $282 | $286.11 | -1.44% | 38 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $220 → $210 | $427.92 | -50.93% | 7 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $55 → $52 | $25.07 | +107.42% | 5 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $175 → $173 | $174.04 | -0.60% | 3 | Apr 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $156 → $120 | $28.25 | +324.78% | 17 | Feb 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $145 → $148 | $13.95 | +960.93% | 19 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $88 → $82 | $81.76 | +0.29% | 4 | Nov 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $71 → $66 | $47.29 | +39.56% | 4 | Oct 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $43 → $39 | $3.08 | +1,168.29% | 4 | Aug 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $51 → $46 | $36.03 | +27.67% | 1 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $33 → $35 | $9.32 | +275.54% | 1 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $207 → $275 | $655.00 | -58.02% | 2 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19 | $2.31 | +724.30% | 1 | Jun 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $67 → $62 | $8.83 | +602.15% | 12 | Mar 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $16 → $17 | $16.51 | +4.48% | 3 | Feb 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $89 → $83 | $83.42 | -0.50% | 1 | Jan 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Equal-Weight | $10 | $35.47 | -71.81% | 4 | Sep 10, 2018 |
Legend Biotech
Aug 12, 2025
Maintains: Overweight
Price Target: $81 → $83
Current: $37.40
Upside: +121.93%
IO Biotech
Aug 12, 2025
Maintains: Overweight
Price Target: $6 → $4
Current: $1.28
Upside: +212.50%
Vertex Pharmaceuticals
Aug 5, 2025
Maintains: Equal-Weight
Price Target: $460 → $439
Current: $391.03
Upside: +12.27%
Regeneron Pharmaceuticals
Aug 4, 2025
Maintains: Overweight
Price Target: $754 → $761
Current: $556.00
Upside: +36.87%
Biogen
Aug 1, 2025
Maintains: Equal-Weight
Price Target: $146 → $144
Current: $133.11
Upside: +8.18%
argenx SE
Aug 1, 2025
Maintains: Overweight
Price Target: $700 → $766
Current: $637.46
Upside: +20.16%
Sarepta Therapeutics
Jul 29, 2025
Maintains: Equal-Weight
Price Target: $15 → $20
Current: $19.22
Upside: +4.06%
BioMarin Pharmaceutical
Jul 22, 2025
Maintains: Overweight
Price Target: $97 → $96
Current: $57.39
Upside: +67.28%
Insmed
Jul 17, 2025
Maintains: Overweight
Price Target: $102 → $108
Current: $121.72
Upside: -11.27%
Ryder System
Jul 15, 2025
Initiates: Positive
Price Target: $215
Current: $180.63
Upside: +19.03%
Apr 25, 2025
Maintains: Overweight
Price Target: $130 → $135
Current: $121.05
Upside: +11.52%
Apr 11, 2025
Maintains: Equal-Weight
Price Target: $6.2 → $6
Current: $3.57
Upside: +68.07%
Apr 9, 2025
Maintains: Equal-Weight
Price Target: $39 → $32
Current: $26.73
Upside: +19.72%
Mar 12, 2025
Maintains: Overweight
Price Target: $15 → $5
Current: $0.82
Upside: +513.50%
Mar 7, 2025
Assumes: Overweight
Price Target: $41 → $33
Current: $13.95
Upside: +136.56%
Feb 21, 2025
Maintains: Buy
Price Target: $160 → $178
Current: $159.02
Upside: +11.94%
Feb 18, 2025
Upgrades: Buy
Price Target: $56
Current: $34.58
Upside: +61.94%
Jan 31, 2025
Maintains: Buy
Price Target: $57 → $55
Current: $32.65
Upside: +68.45%
Nov 26, 2024
Downgrades: Underweight
Price Target: $10 → $3
Current: $2.12
Upside: +41.51%
Jun 21, 2024
Maintains: Equal-Weight
Price Target: $8 → $11
Current: $17.15
Upside: -35.84%
Jun 18, 2024
Downgrades: Equal-Weight
Price Target: $38 → $8
Current: $1.48
Upside: +442.37%
May 9, 2024
Upgrades: Equal-Weight
Price Target: $7
Current: $2.87
Upside: +144.33%
Apr 22, 2024
Maintains: Overweight
Price Target: $34
Current: $21.35
Upside: +59.25%
Mar 26, 2024
Maintains: Underweight
Price Target: $32
Current: $22.46
Upside: +42.51%
Aug 14, 2023
Maintains: Equal-Weight
Price Target: $21 → $19
Current: $3.63
Upside: +424.14%
Mar 27, 2023
Maintains: Underweight
Price Target: $2 → $1
Current: $0.79
Upside: +26.58%
Mar 3, 2023
Maintains: Underweight
Price Target: $13 → $10
Current: $20.38
Upside: -50.93%
Feb 28, 2023
Downgrades: Equal-Weight
Price Target: $27 → $8
Current: $6.59
Upside: +21.40%
Feb 27, 2023
Maintains: Equal-Weight
Price Target: $57 → $44
Current: $32.25
Upside: +36.46%
Jan 24, 2023
Maintains: Overweight
Price Target: $15 → $13
Current: $3.18
Upside: +308.81%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $140 → $80
Current: $10.00
Upside: +700.40%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $100 → $60
Current: $5.51
Upside: +988.93%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $203 → $216
Current: $112.63
Upside: +91.78%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $7 → $5
Current: $3.08
Upside: +62.34%
Jan 24, 2023
Maintains: Overweight
Price Target: $7 → $5
Current: $2.18
Upside: +129.36%
Dec 6, 2022
Maintains: Overweight
Price Target: $178 → $182
Current: $201.12
Upside: -9.51%
Nov 14, 2022
Maintains: Equal-Weight
Price Target: $12 → $9
Current: $8.48
Upside: +6.13%
Nov 7, 2022
Maintains: Equal-Weight
Price Target: $30 → $40
Current: $48.65
Upside: -17.78%
Nov 4, 2022
Maintains: Overweight
Price Target: $279 → $282
Current: $286.11
Upside: -1.44%
Oct 28, 2022
Maintains: Equal-Weight
Price Target: $220 → $210
Current: $427.92
Upside: -50.93%
May 4, 2022
Maintains: Equal-Weight
Price Target: $55 → $52
Current: $25.07
Upside: +107.42%
Apr 6, 2022
Maintains: Equal-Weight
Price Target: $175 → $173
Current: $174.04
Upside: -0.60%
Feb 1, 2022
Maintains: Overweight
Price Target: $156 → $120
Current: $28.25
Upside: +324.78%
Jan 7, 2022
Maintains: Equal-Weight
Price Target: $145 → $148
Current: $13.95
Upside: +960.93%
Nov 29, 2021
Maintains: Equal-Weight
Price Target: $88 → $82
Current: $81.76
Upside: +0.29%
Oct 12, 2021
Maintains: Equal-Weight
Price Target: $71 → $66
Current: $47.29
Upside: +39.56%
Aug 18, 2021
Maintains: Overweight
Price Target: $43 → $39
Current: $3.08
Upside: +1,168.29%
Aug 16, 2021
Maintains: Equal-Weight
Price Target: $51 → $46
Current: $36.03
Upside: +27.67%
Aug 16, 2021
Maintains: Equal-Weight
Price Target: $33 → $35
Current: $9.32
Upside: +275.54%
Aug 5, 2021
Maintains: Overweight
Price Target: $207 → $275
Current: $655.00
Upside: -58.02%
Jun 24, 2021
Initiates: Buy
Price Target: $19
Current: $2.31
Upside: +724.30%
Mar 8, 2021
Maintains: Overweight
Price Target: $67 → $62
Current: $8.83
Upside: +602.15%
Feb 24, 2021
Maintains: Equal-Weight
Price Target: $16 → $17
Current: $16.51
Upside: +4.48%
Jan 6, 2020
Maintains: Equal-Weight
Price Target: $89 → $83
Current: $83.42
Upside: -0.50%
Sep 10, 2018
Assumes: Equal-Weight
Price Target: $10
Current: $35.47
Upside: -71.81%